73 / 100 SEO Score

Dr. Jared Fischer | Nanotechnology | Best Researcher Award

Assistant Professor at Oregon Health and Science University , United States.

Dr. Jared Fischer 🧬 is an Assistant Professor at the Oregon Health & Science University (OHSU) in the Department of Molecular and Medical Genetics/CEDAR 🧑‍🏫. With a dual degree in Zoology and Chemistry 🧪 from Miami University and a PhD in Molecular Genetics 🧫 from the University of Cincinnati, he has cultivated a rich career in cancer biology, senescence, and in vivo imaging. His innovative work in nanomedicine, cancer detection, and senolytic therapies has led to numerous high-impact publications and grants. Dr. Fischer is not only a prolific researcher 📚 but also a committed educator and mentor to future scientists 👨‍🔬.

PROFILE 

GOOGLE SCHOLAR 

SCOPUS 

ORCID 

🔍 Summary of Suitability:

Dr. Jared Fischer is an outstanding biomedical scientist and faculty member at Oregon Health & Science University (OHSU), serving as Assistant Professor in the Department of Molecular and Medical Genetics/CEDAR. His research career exemplifies consistent innovation, high-impact scholarship, and a commitment to translational medicine. His work spans multiple disciplines, including molecular genetics, cancer biology, nanomedicine, and biomedical imaging. Dr. Fischer has secured prestigious federal and institutional grants and consistently publishes in top-tier journals. Moreover, he has demonstrated exemplary service through education, mentorship, and committee leadership—solidifying his role as a leader and innovator in the research community.

🎓 Education and Experience

🎓 Education:

  • 🧪 BS in Zoology & BA in Chemistry, Miami University (1999–2003)

  • 🧬 PhD in Molecular Genetics, University of Cincinnati (2003–2008)

  • 🔬 Postdoctoral Fellowship in Molecular and Medical Genetics, OHSU (2009–2017)

🏢 Academic Experience:

  • 👨‍🏫 Assistant Professor, OHSU, Molecular & Medical Genetics (2017–Present)

Professional Development 🚀📖

Dr. Fischer’s professional growth is rooted in continuous learning, leadership, and service 📈. He completed the Leadership Development Course from Brave Heart Consulting in 2024 🧠 and was certified by the Mentorship Academy in 2023. Actively involved in mentoring underrepresented students 👨‍🎓, he has contributed to cancer education through programs like the CURE Program and the Partnership for Scientific Inquiry 🔍. As IACUC vice-chair and editorial reviewer ✍️, his institutional service has significantly impacted research governance and publication. His commitment to advancing scientific education, ethics, and community health underscores his dynamic and evolving career 🎯.

Research Focus 🔍🤖

Dr. Fischer’s research centers on cancer biology 🧫, senescence 🧓, and molecular imaging 🧲, particularly through nanomedicine and bioengineering innovations. His work targets early cancer detection 🧍‍⚕️, tumor progression 🧬, and therapeutic development using multifunctional nanomaterials and senolytic peptides 💊. He is known for pioneering diagnostic assays and nanoparticle-based imaging techniques 🧪, as demonstrated in his recent publications on pancreatic and colorectal cancers. His interdisciplinary focus bridges molecular genetics, biomedical imaging, and computational modeling 🧠, aligning with cutting-edge research in oncology and personalized medicine 🧑‍⚕️. His contributions are shaping next-generation strategies in precision diagnostics and therapeutic delivery 🚀.

Awards and Honors 🏆🎖️

  • 🧾 OHSU “Paper of the Month” for PNAS publication, December 2016

  • 🧑‍🎓 Graduate Student of the Year, University of Cincinnati, Department of Molecular Genetics, 2008

  • 🎤 Invited Speaker at Cambridge University, Cold Spring Harbor, and various ACS events

  • 🎗️ Recognized across high-profile media (Nature, Science News, Forbes, JAMA) for breakthrough cancer diagnostics research

Publications & Citations 📚

📘 2025

  • 🧬 Early detection of pancreatic cancer by protease-activated nanosensor assayPublished in Science Translational Medicine, featured in Nature, Science News, Forbes 📈

📗 2024

  • 🧪 Profiling protease cleavage in plasma for pancreatic cancerPublished in Scientific Reports

  • 🧫 Tumor-immune hybrid cells and colorectal cancer metastasis via CTLA4Published in Clinical and Experimental Medicine

📙 2023

  • 💡 Ultrafast ultrasound imaging using blinking nanoparticlesPublished in Nano Letters

  • 🧬 Gas-stabilizing nanoparticles for cancer therapyPublished in Advanced Materials Interfaces

📗 2022

  • ⚗️ Hybrid PLGA nanoparticles for enzyme therapyPublished in Pharmaceutics

  • 🔬 Computational design of TP63-TP53 inhibitorsPublished in Molecular Cancer Therapeutics

📘 2021

  • 🧠 Modeling FOXO4-TP53 to create senolytic peptidesPublished in EBioMedicine

  • 🔍 Label-free enrichment of rare neoplastic cells using microfluidicsPublished in Communications Biology

📕 2020

  • 📊 Weight loss, biomarkers & cancer riskPublished in Surg Obes Relat Dis

📘 2019

  • 🧫 Silica cloaking of adenovirus for gene deliveryPublished in Journal of Controlled Release

📙 2018

  • 🧬 Cell fusion and hybrid circulating tumor cellsPublished in Science Advances, highly cited and shared 📈

📗 2017

  • 🧬 Genetic divergence in tumor evolutionPublished in Nature Genetics, highly cited and impactful 📈

📕 2016

  • 🧬 TgfβR2 in intestinal stem cellsPublished in PNAS, earned “Paper of the Month” at OHSU 🏆

  • 🧪 Pms2 ATPase domain studyPublished in DNA Repair

📘 2014

  • 🧬 Apc-deficient crypts and chemopreventionPublished in Carcinogenesis

📕 2012

  • 🧬 Phenotypic outcomes of Apc lossPublished in Oncogene

📙 2008–2006 (select highlights)

  • 🧬 Mutation in aging micePublished in Aging Cell

  • 🔍 Loss of heterozygosity in mouse tissuesPublished in Mutation Research

  • 🧫 Co-mutagenic effects of arsenic and benzo[a]pyrenePublished in Mutation Research

📗 2004–2003

  • 🧬 Evolution of Pneumocystis speciesPublished in Microbiology & J Eukaryotic Microbiology

🔍 Conclusion:

Dr. Jared Fischer is a truly deserving nominee for the Best Researcher Award. His body of work demonstrates not only scientific rigor and innovation but also a profound impact on patient care, early disease detection, and therapeutic development. His interdisciplinary approach, dedication to mentoring, and consistent scholarly output position him among the top-tier researchers advancing modern medicine today.

 

 

Jared Fischer | Nanotechnology | Best Researcher Award

You May Also Like